Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » Trials & Approvals

Trials & Approvals

Print

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Recent Articles

  BeiGene Starts China Trial of PI-1 Drug in Hodgkin Lymphoma
  Immunitor Reports Positive Data for Liver Cancer Immunotherapy
  Asieris Pharma Doses First Patient in China Bladder Cancer Trial
  Athenex, a US-China Biopharma, Starts US Trial of Oral Chemotherapy
  JHL Starts European Trial of MabThera/Rituxan Biosimilar for RA
  AstraZeneca's Tagrisso Approved in China Following Priority Review
  Tarrex Biopharma, a US-China Startup, Approved to Start US Cancer Drug Trial
  CFDA Approves Pfizer Oral Arthritis Treatment for China Use
  Chi-Med's Lead Candidate Passes Phase III Colorectal Cancer Test
  Kite's Fosun-Partnered CAR-T Immunotherapy Posts Strong Phase III Data
 
Login